RevOpsis Therapeutics
PrivateLast Round
VC Round
Sep 16, 2025
Total Funding Raised
$18.3M
Momentum Score
50 /100
Company Overview
RevOpsis Therapeutics is a biopharmaceutical company that develops multispecific antibody treatments for complex diseases, with an initial focus on retinal vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevOpsis Therapeutics Comps
Public and private peers based on sector, stage, and business model.
RevOpsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 16, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Seed | Apr 25, 2024 |
RevOpsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Eye Institute | Grant |
| ExSight Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 351% MoM, from 227 to 1K.
- Sep 16, 2025
Developing multispecific antibody treatments for eye diseases.
RevOpsis Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RevOpsis Therapeutics's valuation, stock price, and market status.
